Clinical Trial

A Clinical Study of HRS-7156 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 29, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this Phase I study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-7156 in healthy participants.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-30
Trial Details
NCT Number NCT07601087
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Heart Failure
Enrollment 66 participants
Start Date 2026-06-12
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-29